Study on the Screening of Anti‐Osteoporosis Components in Processed Epimedium‐Based on Spectrum‐Effect Analysis
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202402936 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Jinling Liang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Changchun University of Traditional Chinese Medicine, Changchun, China. Hauptthemen laut MEDLINE: Epimedium, Osteoporosis, Antioxidants, Drugs, Chinese Herbal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jilin Provincial Department of Science and Technology Fund Project.
Abstract (Originalsprache)
Epimedium (EP) is a traditional Chinese medicine that has been used to treat osteoporosis for several years, but its mechanism of action is unclear. We used ultrahigh‐performance liquid chromatography coupled with triple–quadrupole mass spectrometry (UPLC–QQQ–MS/MS) to detect the components of raw and processed EP samples. The antioxidant activities of the various tested compounds were evaluated using 1,1‐diphenyl‐2‐trinitrophenylhydrazine (DPPH), and their antiosteoporosis effects were assessed in H 2 O 2 ‐stimulated MC3T3 cells and zebrafish embryos. The correlation between the chemical ingredients and efficacy indicators was determined using Pearson correlation analysis. Furthermore, the efficacy of the active ingredients in treating osteoporosis was verified through the implementation of network pharmacology and the application of molecular docking techniques, providing a more comprehensive understanding of their therapeutic potential. The pharmacologically active ingredients were quercetin, Epimedium B, Baohuoside I, and anhydroicaritin‐7‐O‐glucoside. Moreover, network pharmacology and molecular docking studies demonstrated that the four active components could have antiosteoporosis effects by influencing AKT1 and PTGS2. This study provides a basis for future research on the pharmacokinetics of EP and serves as a useful guide for further exploration of EP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Changchun University of Traditional Chinese Medicine, Changchun, China.
- Department of Nephrology, The First Hospital of Jilin University, Changchun, China.
- Jilin Ginseng Academy, Changchun University of Traditional Chinese Medicine, Changchun, China.
- Innovation and Practice Center, Changchun University of Traditional Chinese Medicine, Changchun, China.
ORCID-Profile: Tianyang Xu
Förderung
- Jilin Provincial Department of Science and Technology Fund Project
Zitieren
APA
Liang, J., Liu, J., Sun, W., Li, P., Sun, H., Cao, W., Dai, Y., Xu, T., & Yu, P. (2025). Study on the Screening of Anti‐Osteoporosis Components in Processed Epimedium‐Based on Spectrum‐Effect Analysis. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202402936
Vancouver
Liang J, Liu J, Sun W, Li P, Sun H, Cao W, et al. Study on the Screening of Anti‐Osteoporosis Components in Processed Epimedium‐Based on Spectrum‐Effect Analysis. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202402936
BibTeX
@article{Liang2025,
author = {Liang, Jinling and Liu, Jia and Sun, Weixia and Li, Pan and Sun, Huaizhu and Cao, Wenxuan and Dai, Yulin and Xu, Tianyang and Yu, Peng},
title = {Study on the Screening of Anti‐Osteoporosis Components in Processed Epimedium‐Based on Spectrum‐Effect Analysis},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202402936}
}
EUVIMED